The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Clinical Characteristics and Relationship of Acute Kidney Injury With the Severity of Disease and Death in COVID-19 Patients: A Review
|
|
Author(s): Donovan McGrowder (The University of the West Indies, Jamaica), Fabian Miller (The Mico University College, Jamaica & The University of the West Indies, Jamaica), Magdalene Nwokocha (The University of the West Indies, Jamaica), Melisa Anderson Cross (University of Technology, Jamaica), Cameil Wilson-Clarke (The University of the West Indies, Jamaica), Shelly McFarlane (The University of the West Indies, Jamaica)and Lorenzo Gordon (Caribbean School of Medical Sciences, Jamaica)
Copyright: 2023
Pages: 31
Source title:
Ecological and Evolutionary Perspectives on Infections and Morbidity
Source Author(s)/Editor(s): P.A. Azeez (Salim Ali Centre for Ornithology and Natural History, Coimbatore, India), P.P. Nikhil Raj (Amrita School of Engineering, Amrita Vishwa Vidyapeetham, India)and R. Mohanraj (Bharathidasan University, India)
DOI: 10.4018/978-1-7998-9414-8.ch010
Purchase
|
Abstract
Globally, the coronavirus disease 2019 (COVID-19) pandemic has adversely affected healthcare with significant morbidity and mortality among patients due to the virulent effects of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The kidneys and other organs are infected and the development of renal disorders such as acute kidney injury (AKI) and subsequently chronic renal disease if there is no clinical intervention. There is increasing evidence of more COVID-19 patients developing AKI, and incidence of mild, moderate and severe stages of the disease. There is also evidence of significant morbidity and mortality, especially in patients with severe AKI admitted to the intensive care units (ICU). We reviewed the recent publications in PubMed, Google Scholar, Embase and Cochrane library relating to AKI in COVID-19 patients. This review examines (i) multifactorial causes of AKI in COVID-19 and the pathophysiology of this renal disorder, (ii) incidence of AKI in COVID-19 as well as the same in mild, moderate and severe disease, (iii) the association between the incidence of AKI and disease severity as well as mortality in patients with confirmed COVID-19, and (iv) incidence of renal replacement therapy among COVID-19 patients with AKI. The evidence points to the need for early therapeutic intervention and multidisciplinary supportive care for COVID-19 patients. This is critical for COVID-19 patients with comorbidities such as diabetes mellitus, hypertension and cardiovascular diseases as their renal function may be compromised.
Related Content
|
Kedmon Nyasha Hungwe, Ashley R. Rakatsinzwa, Felix Mukono.
© 2024.
15 pages.
|
|
Josephine Atieno Otiende.
© 2024.
16 pages.
|
|
Babatunde Adeyeye, Abiodun Salawu.
© 2024.
15 pages.
|
|
Wendo Nabea.
© 2024.
13 pages.
|
|
Billy James, Wilfred W. Wilfred.
© 2024.
16 pages.
|
|
Manisha Nitin Gore, Reshma Patil, Revati Pathak.
© 2024.
16 pages.
|
|
Kgomotso Theledi, Violet M. S Pule.
© 2024.
16 pages.
|
|
|